T32 Urologic Oncology Research Training Program

项目总结/摘要 自1999年成立以来，T32泌尿肿瘤研究培训的主要目标是 纪念斯隆凯特琳癌症中心（MSK）的项目一直在培训选定的泌尿科医生， 在泌尿肿瘤学转化研究中的富有成效的职业生涯。泌尿外科专业研究培训 肿瘤学对于国家癌症研究所（NCI）降低发病率的使命至关重要， 泌尿生殖系统癌症的死亡率约占美国所有癌症相关死亡的10% 随着人口老龄化，预计发病率将稳步上升。拟议 在资助期间，我们寻求继续我们的互动，多学科的研究培训战略， 整合了以下内容：（1）基础，临床和翻译研究人员的多学科教师 跨学科的外科，医学，癌症生物学和治疗，分子病理学和 遗传学、免疫疗法、分子放射学、生物统计学和流行病学，以及实验室医学， (2)根据T32学员的研究兴趣和目标量身定制的密集指导研究实习， (3)一个核心课程的必要教学和讨论为基础的课程，以提高质量的 实践研究培训，（4）关于赠款撰写和职业发展的结构化职业发展讲习班 发展奖，以及（5）选修活动，让T32学员进一步沉浸在自己的 在癌症研究的世界，并与同行和既定的领导者网络。每年，2个高 来自MSK泌尿肿瘤学奖学金计划的博士后学员被选中， T32泌尿肿瘤学研究培训计划。他们必须有医学博士学位，必须完成 泌尿外科住院医师培训，必须是符合董事会资格的泌尿科医生。这两名学员得到了 该T32培训补助金在2年内致力于泌尿肿瘤学研究培训， 第二年，以适当的进度为条件。在完成培训后，T32的毕业生 泌尿肿瘤学研究培训计划预计将成为有吸引力的候选人初级教师 在以研究为重点的学术组织任职。在过去的10年里，90%的T32学员 毕业生被录取到学术机构的教师职位，并从事实验室工作。 和/或旨在了解和克服泌尿生殖系统癌症的临床研究。

PROJECT SUMMARY/ABSTRACT Since its inception in 1999, the primary objective of the T32 Urologic Oncology Research Training Program at Memorial Sloan Kettering Cancer Center (MSK) has been to train select urologists for productive careers in translational research in urologic oncology. Dedicated research training in urologic oncology is essential to the mission of the National Cancer Institute (NCI) to reduce morbidity and mortality from genitourinary cancers, which cause about 10% of all cancer-related deaths in the United States and which are expected to rise steadily in incidence as the population ages. For the proposed funding period, we seek to continue our interactive, multidisciplinary research training strategy that integrates the following: (1) a multidisciplinary faculty of basic, clinical, and translational researchers spanning the disciplines of surgery, medicine, cancer biology and therapeutics, molecular pathology and genetics, immunotherapy, molecular radiology, biostatistics and epidemiology, and laboratory medicine, (2) an intensive mentored research practicum tailored to the T32 trainee’s research interests and goals, (3) a core curriculum of required didactic and discussion-based courses to enhance the quality of the hands-on research training, (4) structured career development workshops in grant writing and career development awards, and (5) elective activities that will allow T32 trainees to further immerse themselves in the world of cancer research and to network with peers and established leaders. Each year, 2 highly committed postdoctoral trainees from the Urologic Oncology Fellowship Program at MSK are selected for the T32 Urologic Oncology Research Training Program. They must have an MD, must have completed residency training in urology, and must be board-eligible urologists. These 2 trainees are supported by this T32 training grant during 2 years dedicated to urologic oncology research training, with appointment to the 2nd year contingent on suitable progress. At the completion of their training, graduates of theT32 Urologic Oncology Research Training Program are expected to be attractive candidates for junior faculty appointments at research-focused academic organizations. In the past 10 years, 90% of T32 trainee graduates have matriculated to faculty positions at academic institutions and are engaged in laboratory and/or clinical research aimed at understanding and overcoming genitourinary cancers.